Last year in June, founder Christer Rosén stepped down as CEO of Swiss rare disease play EffRx. More than a year later, a successor has been announced. Lorenzo Bosisio, previously Chief Commercial Officer, was promoted to CEO.

Before joining EffRx in 2013, Bosisio held positions at Amgen, Alexion, PriceWaterhouseCooper, and Tissot Medical.

EffRx also announced that Paolo Agnoluzzi will serve as interim CFO, Josef Hruska has taken on the role as Medical & Medical Affairs Director and that Michael Schmid has joined as International Marketing Director.